SCHEMBL4863718

SCHEMBL4863718

C[C@@H]1Nc2cc(F)ccc2NC1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 1/20 0.59
CREBBP Q92793 1/20 0.59
BRD4 O60885 1/20 0.44
NTRK1 P04629 1/20 0.44
GSK3B P49841 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TSHR P16473 1/20 0.41
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTR7 P34969 4/20 0.38
AKR1B1 P15121 3/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16120451 1.00 BRPF1 (0.59) BRPF1CREBBPBRD4NTRK1GSK3B
SCHEMBL2136049 0.93 BRPF1 (0.59) BRPF1CREBBPBRD4NTRK1GSK3B
SCHEMBL5063224 0.81 NTRK1 (0.52) BRPF1CREBBPBRD4NTRK1MEN1
SCHEMBL7171052 0.79 BRPF1 (0.59) BRPF1CREBBPBRD4GSK3BMEN1
SCHEMBL15823711 0.79 BRPF1 (0.59) BRPF1CREBBPBRD4GSK3BMEN1
SCHEMBL7175133 0.79 BRPF1 (0.59) BRPF1CREBBPBRD4GSK3BMEN1
SCHEMBL6540662 0.79 BRPF1 (0.59) BRPF1CREBBPBRD4GSK3BMEN1
SCHEMBL7170205 0.79 BRPF1 (0.59) BRPF1CREBBPBRD4GSK3BMEN1
SCHEMBL4866364 0.78 MAPT (0.41) MEN1KMT2AMAPTHTR7DRD2
SCHEMBL4869505 0.78 MAPT (0.41) MEN1KMT2AMAPTHTR7DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351709-B2 Estrogen receptor ligands WYETH (US) 2008-04-01 US disclosed
US-20060019961-A1 Estrogen receptor ligands WYETH 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019961-A1 Estrogen receptor ligands GPER1, ESR2, ESR1 BRPF1 1756/4885CREBBP 842/4885BRD4 1413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.